Tulsa Cancer Institute — Tulsa, Oklahoma

Tulsa Cancer Institute is a clinical research site located in Tulsa, Oklahoma, United States 74146.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Tulsa Cancer Institute has participated in 35 clinical trials with 2 currently active.

Therapeutic areas: Locally Advanced or Metastatic Non Small Cell Lung Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma.

Sponsors: Clovis Oncology, Inc., National Cancer Institute (NCI), Gynecologic Oncology Group.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tulsa Cancer Institute?

Tulsa Cancer Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tulsa Cancer Institute conducted?

Tulsa Cancer Institute has 35 clinical trials on record, with 2 currently active. Their work covers Locally Advanced or Metastatic Non Small Cell Lung Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma.

Is Tulsa Cancer Institute accredited by Crixeo Health?

Yes — Tulsa Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tulsa Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.